Topic: chief scientific officer
Digital drug miner Nimbus Therapeutics has brought on Janssen’s global head of lead discovery, Peter Tummino, to serve as its CSO.
The blood cancer-focused immunotherapy company Kiadis Pharma is bringing on Robert Friesen, Ph.D., to serve as its chief scientific officer.
Janssen Research & Development’s global head of discovery, Dashyant Dhanak, Ph.D., is joining Incyte to serve as its chief scientific officer.
Tony Polverino joins Zymeworks as chief scientific officer, a role he held on an interim basis at Gilead unit Kite Pharma.